BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 34611142)

  • 1. Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer's disease.
    Burgaletto C; Platania CBM; Di Benedetto G; Munafò A; Giurdanella G; Federico C; Caltabiano R; Saccone S; Conti F; Bernardini R; Bucolo C; Cantarella G
    Cell Death Dis; 2021 Oct; 12(10):905. PubMed ID: 34611142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutralization of TNFSF10 ameliorates functional outcome in a murine model of Alzheimer's disease.
    Cantarella G; Di Benedetto G; Puzzo D; Privitera L; Loreto C; Saccone S; Giunta S; Palmeri A; Bernardini R
    Brain; 2015 Jan; 138(Pt 1):203-16. PubMed ID: 25472798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effects of curtailing immune susceptibility in an Alzheimer's disease model.
    Di Benedetto G; Burgaletto C; Carta AR; Saccone S; Lempereur L; Mulas G; Loreto C; Bernardini R; Cantarella G
    J Neuroinflammation; 2019 Aug; 16(1):166. PubMed ID: 31409354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial Activation in the Retina of a Triple-Transgenic Alzheimer's Disease Mouse Model (3xTg-AD).
    Salobrar-García E; Rodrigues-Neves AC; Ramírez AI; de Hoz R; Fernández-Albarral JA; López-Cuenca I; Ramírez JM; Ambrósio AF; Salazar JJ
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32012676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease.
    Edwards MM; Rodríguez JJ; Gutierrez-Lanza R; Yates J; Verkhratsky A; Lutty GA
    Exp Eye Res; 2014 Oct; 127():252-60. PubMed ID: 25149907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
    Paouri E; Tzara O; Zenelak S; Georgopoulos S
    J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ablation of TNF-RI/RII expression in Alzheimer's disease mice leads to an unexpected enhancement of pathology: implications for chronic pan-TNF-α suppressive therapeutic strategies in the brain.
    Montgomery SL; Mastrangelo MA; Habib D; Narrow WC; Knowlden SA; Wright TW; Bowers WJ
    Am J Pathol; 2011 Oct; 179(4):2053-70. PubMed ID: 21835156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation, neurodegeneration and protein aggregation in the retina as ocular biomarkers for Alzheimer's disease in the 3xTg-AD mouse model.
    Grimaldi A; Brighi C; Peruzzi G; Ragozzino D; Bonanni V; Limatola C; Ruocco G; Di Angelantonio S
    Cell Death Dis; 2018 Jun; 9(6):685. PubMed ID: 29880901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice.
    Janelsins MC; Mastrangelo MA; Park KM; Sudol KL; Narrow WC; Oddo S; LaFerla FM; Callahan LM; Federoff HJ; Bowers WJ
    Am J Pathol; 2008 Dec; 173(6):1768-82. PubMed ID: 18974297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirtuin 2 Inhibition Improves Cognitive Performance and Acts on Amyloid-β Protein Precursor Processing in Two Alzheimer's Disease Mouse Models.
    Biella G; Fusco F; Nardo E; Bernocchi O; Colombo A; Lichtenthaler SF; Forloni G; Albani D
    J Alzheimers Dis; 2016 Jun; 53(3):1193-207. PubMed ID: 27372638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early miR-155 upregulation contributes to neuroinflammation in Alzheimer's disease triple transgenic mouse model.
    Guedes JR; Custódia CM; Silva RJ; de Almeida LP; Pedroso de Lima MC; Cardoso AL
    Hum Mol Genet; 2014 Dec; 23(23):6286-301. PubMed ID: 24990149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of a 3xTg-AD mouse model of Alzheimer's disease with the senescence accelerated mouse prone 8 (SAMP8) background.
    Virgili J; Lebbadi M; Tremblay C; St-Amour I; Pierrisnard C; Faucher-Genest A; Emond V; Julien C; Calon F
    Synapse; 2018 Apr; 72(4):. PubMed ID: 29341269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal and regional progression of Alzheimer's disease-like pathology in 3xTg-AD mice.
    Belfiore R; Rodin A; Ferreira E; Velazquez R; Branca C; Caccamo A; Oddo S
    Aging Cell; 2019 Feb; 18(1):e12873. PubMed ID: 30488653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up-regulated Pro-inflammatory MicroRNAs (miRNAs) in Alzheimer's disease (AD) and Age-Related Macular Degeneration (AMD).
    Pogue AI; Lukiw WJ
    Cell Mol Neurobiol; 2018 Jul; 38(5):1021-1031. PubMed ID: 29302837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of hippocampal protein expression by a brain penetrant biologic TNF-α inhibitor in the 3xTg Alzheimer's disease mice.
    Jagadeesan N; Roules GC; Chandrashekar DV; Yang J; Kolluru S; Sumbria RK
    J Transl Med; 2024 Mar; 22(1):291. PubMed ID: 38500108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fruitless Wolfberry-Sprout Extract Rescued Cognitive Deficits and Attenuated Neuropathology in Alzheimer's Disease Transgenic Mice.
    Liu SY; Lu S; Yu XL; Yang SG; Liu W; Liu XM; Wang SW; Zhu J; Ji M; Liu DQ; Zhang ZP; Liu RT
    Curr Alzheimer Res; 2018; 15(9):856-868. PubMed ID: 29623840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional Remodeling in Primary Hippocampal Astrocytes from an Alzheimer's Disease Mouse Model.
    Ruffinatti F; Tapella L; Gregnanin I; Stevano A; Chiorino G; Canonico PL; Distasi C; Genazzani AA; Lim D
    Curr Alzheimer Res; 2018; 15(11):986-1004. PubMed ID: 29895250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active full-length DNA Aβ
    Rosenberg RN; Fu M; Lambracht-Washington D
    Alzheimers Res Ther; 2018 Nov; 10(1):115. PubMed ID: 30454039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-128 knockout inhibits the development of Alzheimer's disease by targeting PPARγ in mouse models.
    Liu Y; Zhang Y; Liu P; Bai H; Li X; Xiao J; Yuan Q; Geng S; Yin H; Zhang H; Wang Z; Li J; Wang S; Wang Y
    Eur J Pharmacol; 2019 Jan; 843():134-144. PubMed ID: 30412727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.